Julie Roda

Director, Head of Translational Sciences

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Julie Roda is the Director and Head of Translational Sciences at NGM Biopharmaceuticals Inc in the United States. Her recent research focuses on immunotherapy for multiple myeloma, particularly the targeting of ILT3, as well as the role of the Fibronectin–ILT3 interaction in regulating myeloid cell activity. Additionally, she investigates the influence of hypoxia-inducible factor α subunits on Tie2-expressing macrophages in the context of tumor oxygenation and perfusion in murine breast cancer.

Articles (3)

Year:

2023

Year:

2021

Year:

2020

Collaborators (1)

Ly Vu

Assistant Professor

The University of British Columbia

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Julie Roda

Research Interests

Explore related searches

Contact this professor

About

Articles (3)

A target discovery pipeline identified ILT3 as a target for immunotherapy of multiple myeloma.

The Fibronectin–ILT3 Interaction Functions as a Stromal Checkpoint that Suppresses Myeloid Cells

Hypoxia-Inducible Factor α Subunits Regulate Tie2-Expressing Macrophages That Influence Tumor Oxygen and Perfusion in Murine Breast Cancer

Collaborators (1)

Ly Vu

Make your next move.